Tedco awards $600K to tech firms - Business First of Buffalo:

http://www.annuaire-amerique.info/user_detail.php?u=twireesnimi
The money was granted in collaboratiom withthe U.S. Army Medicaol Research and Materiel Command and the througyhthe Ft. Detrick Technology Transfer The purpose of the technology transfer progra m is to raise awareness of new and developing technologies and fundingb them to transition as viable projectsfor follow-on funding in the market Each company that receiverd funding was awarded approximately $50,00 0 between March 2008 and May making up the initiative’s second rouned of financial awards sinc its $750,000 program extension. The fundss for the program’s second phases were secured by Sen. Barbara Mikulski, and Rep. Roscoe G. Bartlett, “The [Ft.
Detrick Technology Transfefr Initiative] program is enabling area businesses to harness the technologiexs being developed at Fort Detrick and apply them to the commercial said Mikulski. “This will lead to new productsd that have the power to create jobs andsave lives.” Mikulski announcedc the first phase of the tech transfer prograk in March 2005 when 11 companies received in Rockville: The companyh is developing a health care technology callexd miTag system, which is a scalable wireless sensor solutiojn for improving patient flow. in Frederick: The compan is developing a technology called the GeNova Screenhto identify, isolate, and producew antibody-like molecules.
in Rockville: The company is developing an on-demanfd biotech products including a combination vaccine against plagueand anthrax. BioAssay Works LLC in The company is developinga lateral-flow visualp diagnostic test to detect and differentiate single sample multiple pathogenicd poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medicalo product called ClotFoam, which is a intracavitary hemostatic agent. CynerGende IDMP in Frederick: The company is validating and implementing a supplemental diagnosiszof Malaria, HIV, and Dengue using its Infectious Diseasr Multiplex Panel approach, which could allosw for creation of biosensors.
LLC in The company is developing required components and systek framework to enable conversational interfaces fortelemedicinse tools. Such tools would allow professionall medics touse voice, gesture, and otherd human-- computer interactions to access and documentr information in electronic medical records. in Rockville: The compant is developing technology to preserve mammalian cells in dried format that can easil ybe re-hydrated for a variety of uses. LLC in The company is evaluating the effect of Imagilih patented probiotics as a food supplement to enhancew the immune responsiveness of guinea pigs upon immunization or challenge withvirulenft pathogens.
The evaluation will suggest the abilityu of Imagilin patented probiotics to enhance the immunizatioj ofa vaccine. in Baltimore: The companyg is developing micropatterned substrates for viralinfectivityt assays. Juxtopia in Baltimore: The company is customizing its Wearable Assistances and SituationalAwareness (WASA) goggles and service to allowe U.S. Army combat medics to access and document information to electrical medical recorddsvia hands-free voice-requests and in Baltimore: The company is developing cell therapiees to treat brain and spinal cord